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HEPATOCELLULAR carcinoma (HCC), or 
liver cancer, develops like any other can-
cer when there is a mutation to the cellu-
lar machinery that causes the cell 
replicate at a higher rate and/ or results in 
the cell avoiding apoptosis. In particular, 
chronic infections of Hepatitis B 'and, or 
C, can aid the development of HCC by re-
peatedly causing the body's own immune 
system to attack the liver cells, some of 
which are infected by the virus, others 
merely bystanders. This constant cycle of 
damage followed by repair can lead to 
mistakes during repair which in turn 
leads to carcinogenesis. This hypothesis is 
more applicable, at present, to Hepatitis ' 
C. Chronic Hepatitis C causes HCC 
through the stage of cirrhosis. In chronic 
Hepatitis B, however, the integration of 
the viral genome into infected cells can 
directly induce a non-cirrhotic liver to de-
velop HCC. Alternative, repeated con-
sumption of large amounts of ethanol 
can have a similar effect. The toxin afla-
toxin from certain Aspergillus species of 
fungus is carcinogenic and aids carcino-
genesis of Hepatocellular cancer by build-
ing up in the liver. The combined high 
prevalence rates of aflatoxin and Hepati-
tis B in settings like China and West Africa 
has led to relatively high rates of HCC in 
these regions. Other viral Hepatitis, such 
as Hepatitis A have no potential to be-
come a chronic infection and, thus, are 
not related to HCC. 
HCC common in Hep B" C patients 
Diagnosis 
HCC most commonly appears in per-
son with chronic viral Hepatitis (Hepatitis 
B or. C, 20 per cent) or, and with cirrhosis 
(80 per cent). These people undergo sur-
veillance with ultrasound due to cost ef-
fectiveness. Alpha-fetoprotein is a 
marker that is useful if is markedly ele-
vated. At levels less> 20 sensitivity is 41-
65 per cent and specificity is 80-94 per 
cent. However, at levels> 200 sensitivity 
is 31 and specificity is 99 per cent. 
Ultrasound, imaging 
Ultrasound (pic) is often the first im-
aging and screening modality used. On 
Ultrasound, HCC often appears 'as a"small 
hypo-echoic lesion with poorly defined 
margins and coarse irregular internal 
echoes. When . ~he tumour grows, it can 
sometimes appear heterogeneous with fi-
brosis, fatty change and calcifications. 
This heterogeneity can 1001,< similar to cir-
rhosis and the surrounding parenchyma. 
In people with higher suspicion of 
HCC such as rising alpha-fetoprotein and 
des-gamma carboxyprothrombin levels, 
the best methods of diagnosis involves a 
CT scan of the abdomen using intra-
venous contrast agents and three-phase 
scanning (before contrast administra-
tion, immediately after contrast adminis-
,tration, and again after a delay) to 
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increase the ability of the ·radiologist to 
detect small or subtle tumours. It is im-
portant to optimise the parameters of the 
CT examination because the underlying 
liver disease that most people with HCC 
have can make the findings more difficult 
to appreciate. I 
An alternative to CT imaging study 
would ne Magnetic Resonance Imaging 
(MRI). MRI has about the same sensitivity 
for detecting HCC has helical CT. How-
ever, MRI has the advantage of delivering 
high resolution images of the liver with-
out nephrotoxic or ionising radiation. 
Despite the advantages ofMRI, helical CT 
remains the technique of choice among 
radiologists due to the high costs and 
long image acquisition: time ofMRI. 
Classification 
Classification of HCC on CT Liver 
Image Reporting and Data System is the 
new way to standardise/ classify the HCC 
lesion found on CT and MRI. Radiologist 
use this classification system in their im-
aging reports in order to further charac-
terise suspicious lesions. As rule LR1 and 
LR2 get continued surveillance. LR3 has 
variable follow up. LR4 gets close follow 
up, additional imaging or treatment. LRs 
gets treatment. On CT, HCC can have three 
distinct patterns of growth: 
A single large tumour (b) Multiple tu-
mours (c) Po.orly defined tumour with an 
infiltrative growth pattern. 
A biopsy is not needed to confirm the 
diagnosis ofHCC if certain imaging crite-
ria are met. 
Histopathology . 
Macroscopically,. liver cancer appears 
as a nodular or infiltrative tumour. The 
Murtaza Mustafa is a former Assoc Professor FacultY of Medicine 
and Health Sciences, University Malaysia Sabah, with· interest in 
infectious .diseases, multi drug resistant bacteria, tuberculosis, . 
Heliobacter pylori, MRSA, CA-MRSA and Melioidosis. He has 
three books-research monographs and 127 national and intemational 
publications to his credit. 
Em IIIzam is a former medical officer with the Sabah Health Department. He 
presently serves as Senior' Medical Officer with the Sabah Family Planning 
ASSOCiation Clinic. He is a registered occupational Health professional With 
42 international publications to his credit. 
nodular type may be solitary (large mass). 
Or multiple (when developed as a compli-
cation of cirrhosis). Tumour nodules are 
round to oval, grey and green (if the tu-
mour produces bile), well circumscribed 
but not encapsulated. The diffuse type is 
poorly circumscribed and infiltrates the 
portal veins or hepatic vein (rarely). Mi-
croscopically, there are four architectural 
and cytological types (patterns) or HCC 
fibro lamellar, pseudo glandular (ade-
noid), pleomorphic (giant cell) and clear 
cell. In well differentiated forms, tumour 
cells resemble hepatocytes, form trabec-
ulae, cords and nests, and may contain 
bile pigment in cytoplasm. In poorly dif-
ferentiated forms, malignant epithelial 
cells are discohesive, pleomorphic, 
anaplastic, giant. The tumour has a scat 
stroma and central necrosis because of 
poor vascularisation. 
Srnging . 
The prognosis ofHCC is affected by the; 
staging of the tumours as well as the livers 
function due to the effects ofliver cirrho-
sis. There are a number of staging classi-
fication for HCC available. However, due 
to the unique nature of the carcinoma in 
order to fully encompass all tQe features 
that affect the categorisation of the HCC, 
a classification should incorporate tu-
mour size and number, presence of vascu-
lar invasion and extrahepatic spread, liver 
function (levels of serum bilirubin and al-
bumin, presence of ascites and portal hy-
pertension) and general health status of 
the patient (defined bY.ECOG classifica-
tion and the presence of symptoms). Out 
of all staging classification systems avail-
able the Barcelona Clinic Liver Cancer 
staging classification encompasses all of 
the above characteristics. This staging 
classification can be used in order to se-
lect people for treatment. The important 
features that guide treatment include: 
size, spread (stage), presence of tumour 
capsule, presence of hepatic metastases, 
presence of daughter nodules and vascu-
larity of the tumour. MRI is the best stag-
ing method to detect the presence of a 
tumour capsule. 
This series on liver cancer 
concludes next week by examining 
the treatments and prognosis 
for the disease. 
